NCT01209325 · FLOW
Participant flow
Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.
- groups
- description
- Gardasil (quadrivalent HPV types 6, 11, 16, 18) vaccination at weeks 0, 8, 24. quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine laboratory biomarker analysis
- id
- FG000
- title
- Vaccination
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 24
- type
- Lost to Follow-up
- reasons
- group Id
- FG000
- num Subjects
- 1
- type
- Adverse Event
- reasons
- group Id
- FG000
- num Subjects
- 3
- type
- Relocated
- reasons
- group Id
- FG000
- num Subjects
- 8
- type
- Refusal after starting therapy
- reasons
- group Id
- FG000
- num Subjects
- 4
- type
- Protocol Violation
- reasons
- group Id
- FG000
- num Subjects
- 1
- type
- Refusal prior to therapy
- reasons
- group Id
- FG000
- num Subjects
- 2
- type
- Incarceration
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 149
- comment
- Enrolled
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 145
- type
- Eligible
- achievements
- group Id
- FG000
- num Subjects
- 144
- type
- Received First Vaccine Injection
- achievements
- group Id
- FG000
- num Subjects
- 141
- type
- Received Second Vaccine Injection
- achievements
- group Id
- FG000
- num Subjects
- 138
- type
- Received Third Vaccine Infjection
- achievements
- group Id
- FG000
- num Subjects
- 124
- type
- Returned After Week 28
- achievements
- group Id
- FG000
- num Subjects
- 106
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 43
- type
- NOT COMPLETED
- title
- Overall Study
Complete source fields
- groups
- description
- Gardasil (quadrivalent HPV types 6, 11, 16, 18) vaccination at weeks 0, 8, 24. quadrivalent human papillomavirus (types 6, 11, 16, 18) recombinant vaccine laboratory biomarker analysis
- id
- FG000
- title
- Vaccination
- periods
- drop Withdraws
- reasons
- group Id
- FG000
- num Subjects
- 24
- type
- Lost to Follow-up
- reasons
- group Id
- FG000
- num Subjects
- 1
- type
- Adverse Event
- reasons
- group Id
- FG000
- num Subjects
- 3
- type
- Relocated
- reasons
- group Id
- FG000
- num Subjects
- 8
- type
- Refusal after starting therapy
- reasons
- group Id
- FG000
- num Subjects
- 4
- type
- Protocol Violation
- reasons
- group Id
- FG000
- num Subjects
- 1
- type
- Refusal prior to therapy
- reasons
- group Id
- FG000
- num Subjects
- 2
- type
- Incarceration
- milestones
- achievements
- group Id
- FG000
- num Subjects
- 149
- comment
- Enrolled
- type
- STARTED
- achievements
- group Id
- FG000
- num Subjects
- 145
- type
- Eligible
- achievements
- group Id
- FG000
- num Subjects
- 144
- type
- Received First Vaccine Injection
- achievements
- group Id
- FG000
- num Subjects
- 141
- type
- Received Second Vaccine Injection
- achievements
- group Id
- FG000
- num Subjects
- 138
- type
- Received Third Vaccine Infjection
- achievements
- group Id
- FG000
- num Subjects
- 124
- type
- Returned After Week 28
- achievements
- group Id
- FG000
- num Subjects
- 106
- type
- COMPLETED
- achievements
- group Id
- FG000
- num Subjects
- 43
- type
- NOT COMPLETED
- title
- Overall Study
Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f
Preserved source evidence · Not medical advice
Triangle